The mini-driver model of polygenic cancer evolution (original) (raw)

• Garraway, L. A. & Lander, E. S. Lessons from the cancer genome. Cell 153, 17–37 (2013).
  Article CAS Google Scholar
• Leiserson, M. D. et al. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat. Genet. 47, 106–114 (2015).
  Article CAS Google Scholar
• Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546–1558 (2013).
  Article CAS Google Scholar
• Stratton, M. R., Campbell, P. J. & Futreal, P. A. The cancer genome. Nature 458, 719–724 (2009).
  Article CAS Google Scholar
• Marx, V. Cancer genomes: discerning drivers from passengers. Nat. Methods 11, 375–379 (2014).
  Article CAS Google Scholar
• Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495–501 (2014).
  Article CAS Google Scholar
• Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306–313 (2012).
  Article CAS Google Scholar
• Merlo, L. M., Pepper, J. W., Reid, B. J. & Maley, C. C. Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 6, 924–935 (2006).
  Article CAS Google Scholar
• Amos-Landgraf, J. M. et al. Sex disparity in colonic adenomagenesis involves promotion by male hormones, not protection by female hormones. Proc. Natl Acad. Sci. USA 111, 16514–16519 (2014).
  Article CAS Google Scholar
• Figueiredo, J. C. et al. Genome-wide diet–gene interaction analyses for risk of colorectal cancer. PLoS Genet. 10, e1004228 (2014).
  Article Google Scholar
• Beerenwinkel, N. et al. Genetic progression and the waiting time to cancer. PLoS Comput. Biol. 3, e225 (2007).
  Article Google Scholar
• Bansal, V., Libiger, O., Torkamani, A. & Schork, N. J. Statistical analysis strategies for association studies involving rare variants. Nat. Rev. Genet. 11, 773–785 (2010).
  Article CAS Google Scholar
• Bodmer, W. & Bonilla, C. Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet. 40, 695–701 (2008).
  Article CAS Google Scholar
• Hindorff, L. A., Gillanders, E. M. & Manolio, T. A. Genetic architecture of cancer and other complex diseases: lessons learned and future directions. Carcinogenesis 32, 945–954 (2011).
  Article CAS Google Scholar
• Cheetham, S. W., Gruhl, F., Mattick, J. S. & Dinger, M. E. Long noncoding RNAs and the genetics of cancer. Br. J. Cancer 108, 2419–2425 (2013).
  Article CAS Google Scholar
• Fredriksson, N. J., Ny, L., Nilsson, J. A. & Larsson, E. Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types. Nat. Genet. 46, 1258–1263 (2014).
  Article CAS Google Scholar
• Hayes, J., Peruzzi, P. P. & Lawler, S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol. Med. 20, 460–469 (2014).
  Article CAS Google Scholar
• Horn, S. et al. TERT promoter mutations in familial and sporadic melanoma. Science 339, 959–961 (2013).
  Article CAS Google Scholar
• Huang, F. W. et al. Highly recurrent TERT promoter mutations in human melanoma. Science 339, 957–959 (2013).
  Article CAS Google Scholar
• Weinhold, N., Jacobsen, A., Schultz, N., Sander, C. & Lee, W. Genome-wide analysis of noncoding regulatory mutations in cancer. Nat. Genet. 46, 1160–1165 (2014).
  Article CAS Google Scholar
• Zeron-Medina, J. et al. A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection. Cell 155, 410–422 (2013).
  Article CAS Google Scholar
• Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
  Article CAS Google Scholar
• Imamura, Y. et al. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review. Mol. Cancer 13, 135 (2014).
  Article Google Scholar
• Sansom, O. Tissue-specific tumour suppression by APC. Adv. Exp. Med. Biol. 656, 107–118 (2009).
  Article CAS Google Scholar
• The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012).
• Lamlum, H. et al. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat. Med. 5, 1071–1075 (1999).
  Article CAS Google Scholar
• Albuquerque, C. et al. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the β-catenin signaling cascade. Hum. Mol. Genet. 11, 1549–1560 (2002).
  Article CAS Google Scholar
• Schneikert, J., Grohmann, A. & Behrens, J. Truncated APC regulates the transcriptional activity of β-catenin in a cell cycle dependent manner. Hum. Mol. Genet. 16, 199–209 (2007).
  Article CAS Google Scholar
• Segditsas, S. et al. APC and the three-hit hypothesis. Oncogene 28, 146–155 (2009).
  Article CAS Google Scholar
• Tuupanen, S. et al. Allelic imbalance at rs6983267 suggests selection of the risk allele in somatic colorectal tumor evolution. Cancer Res. 68, 14–17 (2008).
  Article CAS Google Scholar
• Dewhurst, S. M. et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 4, 175–185 (2014).
  Article CAS Google Scholar
• Pugh, C. W. & Ratcliffe, P. J. The von Hippel–Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin. Cancer Biol. 13, 83–89 (2003).
  Article CAS Google Scholar
• Shen, C. et al. Genetic and functional studies implicate _HIF1_α as a 14q kidney cancer suppressor gene. Cancer Discov. 1, 222–235 (2011).
  Article CAS Google Scholar
• McFarland, C. D., Korolev, K. S., Kryukov, G. V., Sunyaev, S. R. & Mirny, L. A. Impact of deleterious passenger mutations on cancer progression. Proc. Natl Acad. Sci. USA 110, 2910–2915 (2013).
  Article CAS Google Scholar
• Favero, F. et al. Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macroevolution of a double minute chromosome. Ann. Oncol. 26, 880–887 (2015).
  Article CAS Google Scholar
• Korolev, K. S., Xavier, J. B. & Gore, J. Turning ecology and evolution against cancer. Nat. Rev. Cancer 14, 371–380 (2014).
  Article CAS Google Scholar
• Marusyk, A. et al. Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature 514, 54–58 (2014).
  Article CAS Google Scholar
• Reilly, K. M. & Van Dyke, T. It takes a (dysfunctional) village to raise a tumor. Cell 135, 408–410 (2008).
  Article CAS Google Scholar
• Tabassum, D. P. & Polyak, K. Tumorigenesis: it takes a village. Nat. Rev. Cancer 15, 473–483 (2015).
  Article CAS Google Scholar
• Tomlinson, I. P. Game-theory models of interactions between tumour cells. Eur. J. Cancer 33, 1495–1500 (1997).
  Article CAS Google Scholar
• Tomlinson, I. P. & Bodmer, W. F. Modelling the consequences of interactions between tumour cells. Br. J. Cancer 75, 157–160 (1997).
  Article CAS Google Scholar
• Miller, B. E., Miller, F. R., Wilburn, D. & Heppner, G. H. Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors. Cancer Res. 48, 5747–5753 (1988).
  CAS PubMed Google Scholar
• Axelrod, R., Axelrod, D. E. & Pienta, K. J. Evolution of cooperation among tumor cells. Proc. Natl Acad. Sci. USA 103, 13474–13479 (2006).
  Article CAS Google Scholar
• Cleary, A. S., Leonard, T. L., Gestl, S. A. & Gunther, E. J. Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature 508, 113–117 (2014).
  Article CAS Google Scholar
• Inda, M. M. et al. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev. 24, 1731–1745 (2010).
  Article CAS Google Scholar
• Turke, A. B. et al. Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. Cancer Cell 17, 77–88 (2010).
  Article CAS Google Scholar
• Aceto, N. et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110–1122 (2014).
  Article CAS Google Scholar
• Calbo, J. et al. A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. Cancer Cell 19, 244–256 (2011).
  Article CAS Google Scholar
• Marusyk, A. & Polyak, K. Tumor heterogeneity: causes and consequences. Biochim. Biophys. Acta 1805, 105–117 (2010).
  CAS PubMed Google Scholar
• Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807–1812 (2008).
  Article CAS Google Scholar
• Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058–1066 (2009).
  Article CAS Google Scholar
• Davoli, T. et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 155, 948–962 (2013).
  Article CAS Google Scholar
• Creixell, P. et al. Pathway and network analysis of cancer genomes. Nat. Methods 12, 615–621 (2015).
  Article CAS Google Scholar
• Krogan, N. J., Lippman, S., Agard, D. A., Ashworth, A. & Ideker, T. The cancer cell map initiative: defining the hallmark networks of cancer. Mol. Cell 58, 690–698 (2015).
  Article CAS Google Scholar
• Pe'er, D. & Hacohen, N. Principles and strategies for developing network models in cancer. Cell 144, 864–873 (2011).
  Article CAS Google Scholar
• Gonzalez-Perez, A. & Lopez-Bigas, N. Functional impact bias reveals cancer drivers. Nucleic Acids Res. 40, e169 (2012).
  Article CAS Google Scholar
• Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214–218 (2013).
  Article CAS Google Scholar
• Tamborero, D., Lopez-Bigas, N. & Gonzalez-Perez, A. Oncodrive-CIS: a method to reveal likely driver genes based on the impact of their copy number changes on expression. PLoS ONE 8, e55489 (2013).
  Article CAS Google Scholar
• Gundem, G. et al. IntOGen: integration and data mining of multidimensional oncogenomic data. Nat. Methods 7, 92–93 (2010).
  Article CAS Google Scholar
• Salk, J. J., Fox, E. J. & Loeb, L. A. Mutational heterogeneity in human cancers: origin and consequences. Annu. Rev. Pathol. 5, 51–75 (2010).
  Article CAS Google Scholar
• Balmain, A., Gray, J. & Ponder, B. The genetics and genomics of cancer. Nat. Genet. 33, 238–244 (2003).
  Article CAS Google Scholar
• Heitzer, E. & Tomlinson, I. Replicative DNA polymerase mutations in cancer. Curr. Opin. Genet. Dev. 24, 107–113 (2014).
  Article CAS Google Scholar
• Anderson, A. R., Weaver, A. M., Cummings, P. T. & Quaranta, V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127, 905–915 (2006).
  Article CAS Google Scholar
• Sidow, A. & Spies, N. Concepts in solid tumor evolution. Trends Genet. 31, 208–214 (2015).
  Article CAS Google Scholar
• Reiter, J. G., Bozic, I., Allen, B., Chatterjee, K. & Nowak, M. A. The effect of one additional driver mutation on tumor progression. Evol. Appl. 6, 34–45 (2013).
  Article CAS Google Scholar
• Bozic, I. et al. Accumulation of driver and passenger mutations during tumor progression. Proc. Natl Acad. Sci. USA 107, 18545–18550 (2010).
  Article CAS Google Scholar
• Crespi, B. The evolutionary biology of child health. Proc. Biol. Sci. 278, 1441–1449 (2011).
  Article Google Scholar
• Peer, P. G., van Dijck, J. A., Hendriks, J. H., Holland, R. & Verbeek, A. L. Age-dependent growth rate of primary breast cancer. Cancer 71, 3547–3551 (1993).
  Article CAS Google Scholar
• Egeblad, M., Nakasone, E. S. & Werb, Z. Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell 18, 884–901 (2010).
  Article CAS Google Scholar
• Kandoth, C. et al. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67–73 (2013).
  Article Google Scholar
• Abbott, K. L. et al. The Candidate Cancer Gene Database: a database of cancer driver genes from forward genetic screens in mice. Nucleic Acids Res. 43, D844–D848 (2015).
  Article CAS Google Scholar
• Shain, A. & Pollack, J. The spectrum of SWI/SNF mutations, ubiquitous in human cancers. PLoS ONE 8, e55119 (2013).
  Article Google Scholar
• Church D. N. et al. Prognostic significance of POLE proofreading mutations in endometrial cancer. J. Natl Cancer Inst. 107, dju402 (2015).
  Article Google Scholar